The Entrepreneurial Scientist brings research out of the lab to start a business. The challenges come hard and fast – market and early adopter identification; user needs specification; product development; pilots or trials; go-to-market preparations; funding; critical hiring at the initial phase, etc.
Topics: Investments, MedTech / HealthTech / BioTech, Quantum Technologies, Startups
Deep Tech innovations can play a critical role in addressing global developmental challenges. Priority sectors such as healthcare, mobility, agriculture, urban solutions are seeing strong startup and innovation activities to deliver impact and achieve sustainable development, particularly in Asia, home to about 60% of the world’s population.
Topics: Investments
Deep Tech spans from scientific discovery or engineering innovation and has the potential to be disruptive. Deep Tech promises solutions to real-life problems within healthcare, energy, food and sustainability, amongst others.
Topics: Artificial Intelligence / Deep Learning / Machine Learning / Robotics, Investments, MedTech / HealthTech / BioTech, Startups
Deep Tech startups often struggle to secure funding with investors who may not have the expertise and knowledge to understand the value of their technologies. At the same time, many investors tend to shy away from Deep Tech companies because they see them as “moonshots,” cash burn- intensive and challenging to support in the long run. However, in Southeast Asia, Deep Tech fundraising looks to be promising as more startups and investments are emerging from the countries in the region.
Topics: Investments, Startups
Morning Pitch is a pitching platform hosted by Deloitte Tohmatsu Venture Support. This platform helps startups form business alliances and partnerships with large corporations, corporate venture capital and venture capital firms. The focus for this Morning Pitch on 21 August 2020 is on Deep Tech.
Topics: Investments, Startups
As most of society has experienced, the pandemic has affected many economies across the globe. For economies to emerge stronger post-COVID-19, resilience and reliability are key. Countries will have to uncover and master major trends reshaping the global economy and hasten their digitals shifts and structural transformations.
Topics: Artificial Intelligence / Deep Learning / Machine Learning / Robotics, Investments, MedTech / HealthTech / BioTech
According to the Biotechnology Innovation Organisation, BioTech is “technology based on biology – harness[sing] cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet.” More than just a tool for human health, BioTech is involved in many industries including energy and fuel, and agriculture and food, where innovations in the field helps address some of the world’s most pressing issues.
Topics: Investments, MedTech / HealthTech / BioTech, Startups
Deep Technology (Deep Tech) can solve significant societal problems in areas such as healthcare, urban mobility, sustainability and other issues. However, the research behind such technologies may take years before a discovery emerges.
Topics: Artificial Intelligence / Deep Learning / Machine Learning / Robotics, Investments, Startups, Talent
Calling out to all Angel Investors, Entrepreneurs, VCs, fund managers, academics, corporates and anyone else who wish to learn more about Angel Investing in ASEAN:
Topics: Investments
AngelCentral’s monthly by-invite pitch day showcases a curated pool of startups pitching to raise funds. During the session, you will also find out more about what AngelCentral does to build an active community of effective and competent angel investors in Southeast Asia.
Topics: Investments
Calling out to all Angel Investors, Entrepreneurs, VCs, fund managers, academics, corporates and anyone else who wish to learn more about Angel Investing in ASEAN!
Topics: Investments
In the first half of 2019, the total new money entering the Asia Pacific HealthTech sector was US$2.5 billion across 140 deals. And the second quarter of 2019 was the 8th consecutive $1 billion or more quarter for HealthTech in Asia. While the number of deals is going down, the individual deals are getting larger and more likely to be in later-stage companies (Galen Growth Asia 2019 Half Year Asia HealthTech Landscape report).